+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product and Service, Technology, Application, End-User, and Geography

  • PDF Icon

    Report

  • 240 Pages
  • June 2022
  • Region: Global
  • The Insight Partners
  • ID: 5635247
The global genotyping market is expected to grow from US$ 25,191.28 million in 2022 to US$ 79,407.14 million by 2028.

The use of genotyping in drug development for genetic & rare diseases and rising R&D investments in pharmaceutical & biotechnology boost the global genotyping market growth.

Genotyping compares a DNA sequence to another sample or a reference sequence to discover variations in genetic complement. It detects single-nucleotide polymorphisms (SNPs), which are minor differences in genetic sequence within the population. The human genome has about 660 million SNPs, making them the most prevalent kind of genetic variation. They can explain features such as eye color and hereditary disorders such as cystic fibrosis and sickle cell anemia and serve as indicators for developing complicated diseases such as cancer, diabetes, and Alzheimer's. According to the GLOBOCAN database published in 2020, an estimated 28.4 million new cancer cases are predicted to occur in 2040, a 47% increase from the corresponding 19.3 million cases in 2020.

According to the Alzheimer’s Association, in 2022., the number of people living with Alzheimer’s in the US rapidly increases. Alzheimer’s affects more than 6 million Americans of all ages. In 2022, an estimated 6.5 million Americans aged 65 and up have Alzheimer's, out of which 73% of the population is 75 years old or older.

According to the International Diabetes Federation (IDF) consortium, in 2019, type 2 diabetes (T2D) is one of the leading causes of death worldwide, accounting for 4.2 million deaths in 2019. According to the same research, Iran ranks third among 20 countries in the Middle East and North Africa (MENA) in terms of the number of adults with diabetes (5.4 million), estimated that about 9.2 million Iranians may catch the disease by 2030. Type 2 diabetes is a complex metabolic illness caused by genetic and non-genetic (environmental) factors. The heritability of T2D varies between 20% and 80%, indicating that genetic factors play a significant part in the disease's development; the disease's heritable component is polygenic, meaning that multiple genes and their variations contribute to an increased risk of T2D development. The introduction of high-throughput genotyping technologies has greatly advanced our understanding of the genetic components of complex disorders, such as T2D.

Additionally, by comparing polymorphisms in two distinct populations (one healthy and one diseased), genome-wide association studies (GWAS) can uncover links between SNPs and common illness risk.

GWAS can begin to untangle the molecular mechanisms underlying disease states by finding probable causative variables risk stratification. Single-celled organisms, such as bacteria, even have SNPs. SNP genotyping can discriminate between microorganism isolates and might even be accustomed to characterizing antibiotic resistance strains. SNP-based strain detection has relevance in each clinical and pharmaceutical analysis and has been used to study the spread of infectious diseases in humans.

As per the Global Genes Project, 2017, up to 350 million people worldwide suffer from rare diseases. Although individual diseases are rare, they pose significant challenges to the global healthcare system. As per the WHO, in 2020, more than 1.7 million children in India were born with congenital disabilities for which genetic or chromosomal abnormalities are the major causal agent.

Since these conditions are difficult to identify clinically, genotyping is the backbone of diagnostic testing in the population. This rising adoption of prenatal genetic screening to examine children's chromosomal anomalies could prove to be a major driving factor.

Over the last decade, next-generation sequencing (NGS) technology has enabled simultaneous testing of multiple disease genes, from targeted gene panels to exome sequencing (ES) and genomic sequencing (GS). GS is quickly becoming a practical first-stage test as costs decrease and performance improves. More and more studies show that GS can detect an unprecedented range of pathogenic abnormalities in a single laboratory. GS has the potential to provide patients with unbiased, rapid, and accurate molecular diagnostics that transcend diverse clinical indications and complex conditions. Therefore, the use in drug development for genetic and rare diseases across the globe will act as one of the key factors driving the growth of the genotyping markets.

The genotyping market witnessed a surge in the COVID-19 crisis owing to increased demand for COVID-19 genotyping kits. Single nucleotide polymorphism (SNP) genotyping has been used to detect genetic variants of the Covid-19 virus. As the SARS-CoV-2 virus continues to evolve, variants of concern (VOC) could increase transmissibility and impair the efficacy of COVID-19 vaccines. As a response, physicians across the globe began genotyping SARS-CoV-2 variations.

The COVID-19 pandemic increased the demand for genotyping-based research activities to develop COVID diagnostics, vaccines, and therapeutics. Scientists from Brazil and the UK formed the Center for Arbovirus Discovery, Diagnosis, Genomics, and Epidemiology (CADDE) team. Within 48 hours of the first verified case in early March 2020, the team in Brazil sequenced the genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Further, increased product launches such as reagents & kits, bioinformatics, and genotyping services. For instance, In March 2020, Singapore-listed medtech company Biolidics launched its rapid test kit for COVID-19 detection. A manufacturing agreement was made with a manufacturer of a diagnostic kit manufacturer to customize and manufacture the rapid test kits. Biolidics has obtained provisional authorization from Singapore's Health Science Authority (HSA) for its rapid test kit to be used in Singapore.

In addition, In June 2022, CoviEasy"At-Home" self-test kit for COVID-19 was introduced by Genes2Me. One of the top IVD solution manufacturers in India, Genes2Me Pvt. Ltd., launched their CoviEasy Self-Test Rapid Antigen test kit for COVID-19, which is simple to use and provides fast results in 10 minutes. This IVD device offers high sensitivity and concordance of more than 90% accuracy and is supported by an AI-driven mobile app. Thus, the pandemic had a positive impact on the genotyping market.

Based on product and service, the genotyping market is segmented into instruments, reagents & kits, bioinformatics, and genotyping services. In 2022, the reagents and kits segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.

Based on technology, the genotyping market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF), and mass spectrometry, polymerase chain reaction (PCR), and others. In 2022, the polymerase chain reaction (PCR) segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.

Based on application, the genotyping market is segmented into pharmacogenomics, diagnostics & personalized medicine, animal genetics, agricultural biotechnology, and others. In 2022, the diagnostics & personalized medicine segment is expected to account for the largest share of the market. Moreover, the pharmacogenomics segment is expected to register the highest CAGR from 2022 to 2028.

Based on end user, the genotyping market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. In 2022, the diagnostic and research laboratories segment is expected to account for the largest share of the market. Moreover, the pharmaceutical and biopharmaceutical companies segment is expected to register the highest CAGR from 2022 to 2028

National Science Foundation (NSF), Gene People, Globocan, World Health Organization (WHO), National Science Foundation (NSF), International Trade Administration US Department of Commerce, Department of Emergency Medicine, Alzheimer’s Association, International Diabetes Federation (IDF), National Health Service of England, US Centers for Medicare & Medicaid Services, The Spanish Association of Biotech companies (ASEBIO), are among the primary and secondary sources referred to while preparing the report on the genotyping market.

Frequently Asked Questions about the Global Genotyping Market

What is the estimated value of the Global Genotyping Market?

The Global Genotyping Market was estimated to be valued at $25191.28 Million in 2022.

What is the growth rate of the Global Genotyping Market?

The growth rate of the Global Genotyping Market is 20.1%, with an estimated value of $79407.14 Million by 2028.

What is the forecasted size of the Global Genotyping Market?

The Global Genotyping Market is estimated to be worth $79407.14 Million by 2028.

Who are the key companies in the Global Genotyping Market?

Key companies in the Global Genotyping Market include F. Hoffmann, La Roche Ltd., Integrated DNA Technologies, Inc., QIAGEN, MERCK KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc, BioTek Instruments, Inc. and TrimGen Corporation.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Genotyping Market - By Product and Service
1.3.2 Global Genotyping Market - By Technology
1.3.3 Global Genotyping Market - By Application
1.3.4 Global Genotyping Market - By End-User
1.3.5 Global Genotyping Market - By Geography
2. Genotyping Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Genotyping Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Genotyping Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R & amp;D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market - Global Analysis
6.1 Global Genotyping Market Revenue Forecast and Analysis
6.2 Global Genotyping Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Genotyping Market - Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1.1 F. Hoffmann-La Roche Ltd.
6.7.1.2 Illumina, Inc.
6.8 Market Share Analysis of Genotyping Market
7. Global Genotyping Market Revenue and Forecasts To 2028 - by Product and Service
7.1 Overview
7.2 Global Genotyping Market, By Product and Service, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. Genotyping Market Revenue and Forecasts To 2028 - Technology
8.1 Overview
8.2 Global Genotyping Market Share by Technology - 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. Genotyping Market Revenue and Forecasts To 2028 - Application
9.1 Overview
9.2 Global Genotyping Market Share by Application - 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. Genotyping Market Revenue and Forecasts To 2028 - End-User
10.1 Overview
10.2 Global Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. Genotyping Market Revenue and Forecasts to 2028 - Geographical Analysis
11.1 North America: Genotyping Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 North America: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Genotyping Market, by Product and Services, 2019 - 2028 (US$ Million)
11.1.4 North America: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.1.5 North America: Genotyping Market, by Application, 2019 - 2028 (US$ Million)
11.1.6 North America: Genotyping Market, by End User, 2019 - 2028 (US$ Million)
11.1.7 North America: Genotyping Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Genotyping Market, by Product and Services, 2019 - 2028 (US$ Million)
11.1.7.1.4 US: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.1.7.1.5 US: Genotyping Market, by Application, 2019 - 2028 (US$ Million)
11.1.7.1.6 US: Genotyping Market, by End User, 2019 - 2028 (US$ Million)
11.1.7.2 Canada: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Genotyping Market, by Product and Services, 2019 - 2028 (US$ Million)
11.1.7.2.4 Canada: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.1.7.2.5 Canada: Genotyping Market, by Application, 2019 - 2028 (US$ Million)
11.1.7.2.6 Canada: Genotyping Market, by End User, 2019 - 2028 (US$ Million)
11.1.7.3 Mexico: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Genotyping Market, by Product and Services, 2019 - 2028 (US$ Million)
11.1.7.3.4 Mexico: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.1.7.3.5 Mexico: Genotyping Market, by Application, 2019 - 2028 (US$ Million)
11.1.7.3.6 Mexico: Genotyping Market, by End User, 2019 - 2028 (US$ Million)
11.2 Europe: Genotyping Market
11.2.1 Overview
11.2.2 Europe: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.4 Europe: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.5 Europe: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.6 Europe: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.2.7 Europe: Genotyping Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 Germany: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.4 Germany: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.5 Germany: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.6 Germany: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2 France: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 France: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.4 France: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.5 France: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.6 France: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3 UK: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 UK: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.4 UK: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.5 UK: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.6 UK: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4 Italy: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.4 Italy: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.5 Italy: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.6 Italy: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5 Spain: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.4 Spain: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.5 Spain: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.6 Spain: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6 Rest of Europe: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.6 Rest of Europe: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.3 Asia Pacific Genotyping Market Revenue and Forecasts To 2028
11.3.1 Overview
11.3.2 Asia Pacific Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.4 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.5 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.6 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.1.4 Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.1.5 Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.1.6 Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 China: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.2.4 China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.2.5 China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.2.6 China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.3 India Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 India: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.3.4 India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.3.5 India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.3.6 India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.4 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.4.4 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.4.5 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.4.6 South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.5 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.5.4 Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.5.5 Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.5.6 Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.6 Rest of Asia Pacific: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.4 Middle East & Africa Genotyping Market Revenue and Forecasts To 2028
11.4.1 Overview
11.4.2 Middle East & Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.3 Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.4 Middle East & Africa: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.4.6 Middle East & Africa: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.4.7 Middle East & Africa Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.4.7.1 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.1.3 UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.1.4 UAE: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.4.7.1.5 UAE: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.4.7.1.6 UAE: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.4.7.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.2.3 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.2.4 Saudi Arabia: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.4.7.2.5 Saudi Arabia: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)11.4.7.2.6 Saudi Arabia: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.4.7.3 South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 South Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.3.4 South Africa: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.4.7.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.4.7.3.6 South Africa: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: Genotyping Market, by Technology, 2019 - 2028 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.4.7.4.6 Rest of Middle East and Africa: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.5 South And Central America Genotyping Market Revenue and Forecasts To 2028
11.5.1 Overview
11.5.2 South and Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.3 South and Central America Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.4 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.5.5 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.5.6 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.5.7 South and Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.5.7.1 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.1.3 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.7.1.4 Argentina: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)
11.5.7.1.5 Argentina: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.5.7.1.6 Argentina: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)
11.5.7.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.2.3 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.7.2.4 Brazil: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)
11.5.7.2.5 Brazil: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.5.7.2.6 Brazil: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)
11.5.7.3 Rest of South and Central America: Genotyping Market - Revenue and Forecast to 2028 (USD Mn)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South and Central America: Genotyping Market - Revenue and Forecast to 2028 (USD Mn)
11.5.7.3.3 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.7.3.4 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)
11.5.7.3.5 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.5.7.3.6 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)
12. Impact Of COVID-19 Pandemic on Genotyping Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Genotyping Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 F. HOFFMANN-LA ROCHE LTD.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 QIAGEN
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERCK KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 EUROFINS GENOMICS
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 THERMO FISHER SCIENTIFIC INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BioTek Instruments, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 XCELRIS GENOMICS
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TRIMGEN CORPORATION
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 SWOT Analysis
14.9.5 Key Developments
14.10 Illumina, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. The pharmaceutical company partnered with genomic health databases
Table 2. North America Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Genotyping Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 5. North America Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 8. US Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 27. France: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 28. France: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 33. UK: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Genotyping Market, by Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Genotyping Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe: Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million).
Table 47. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 48. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 49. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 50. Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 51. Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 52. Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 53. Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 54. China: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 55. China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 56. China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 57. China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 58. India: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 59. India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 60. India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 61. India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 62. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 63. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 64. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 65. South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 66. Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 67. Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 68. Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 69. Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 70. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 71. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 72. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Ap

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche Ltd.
  • Integrated DNA Technologies, Inc.
  • QIAGEN
  • MERCK KGaA
  • Eurofins Genomics
  • Thermo Fisher Scientific Inc
  • BioTek Instruments, Inc.
  • Xcelris Genomics
  • TrimGen Corporation
  • Illumina, Inc.